Emerald Clinical
Newtown
About Emerald Clinical
George Clinical is a independent Asia-Pacific based clinical research organisation (CRO) with global capabilities differentiated by scientific leadership and extensive site networks. With staff operating in 11 countries, George Clinical provides the full range of clinical trial services to pharmaceutical, medical device and biotech customers, for all trial phases, registration and post-marketing trials. George Clinical combines scientific and clinical leadership with expert trial delivery capability to create a distinctive world-class service. In recent years, George Clinical has managed more than 40,000 patients in trials across more than 1,700 sites. George Clinical’s parent organization, The George Institute for Global Health, is a leader in chronic disease research, with a global network of experts with whom George Clinical engages. George Clinical delivers an operationally supported, internationally recognized scientific leadership service, bringing together an extensive series of investigator networks that allow George Clinical to provide customizable clinical trial excellence from trial design through all aspects of delivery.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $50K – $100K
- Website: emeraldclinical.com
- Phone: +61 280524300
Industries & Categories
Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/emerald-clinical-2225074 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.